Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness.
Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness.
复制标题
对患有严重精神疾病患者的社会心理戒烟干预的系统评价。
DOI：
10.1080/15504263.2021.1944712
复制
发表时间：
2021-07
影响因子：
2.2
通讯作者：
Cabassa LJ
中科院分区：
文献类型：
--
作者：
Hawes MR;Roth KB;Cabassa LJ
吸烟是严重精神疾病(如精神分裂症、躁郁症)患者过早死亡的主要原因。这项系统的文献综述描述了针对SMI患者的心理社会戒烟干预的随机对照试验，评估了他们的方法严谨性，评估了纳入种族/民族和性/性别少数群体的情况，并检查了戒烟结果。符合条件的研究包括2009年至2020年发表的同行评议文章，这些文章考察了SMI患者的心理社会戒烟干预措施。我们使用系统回顾和Meta分析指南的首选报告项目进行审查，并使用方法学质量评级量表来评估方法学的严谨性。共纳入18项研究。根据他们的研究特点(例如，较长的随访时间)，10人被归类为高度方法学严格性，8人根据他们的特征(例如，不打算治疗)被归类为较低方法学严格性。在这些研究中，种族/族裔和性/性别少数群体的代表性不足。检查了一系列的心理社会干预措施，包括动机增强、戒烟教育、认知行为策略和应急管理。大多数研究也提供了戒烟药物(如NRT、安非他酮)，尽管在不同的治疗条件下，提供的药物并不总是一致的。九项研究发现，与对照组相比，干预条件实现了显著更高的戒烟或减少吸烟。最有希望的心理社会戒烟干预措施似乎是从住院精神病室开始的，并使用了跨理论的方法(即，阶段定制的、决定性的平衡)或使用激励访谈框架的个性化电话行为吸烟咨询。需要临床试验设计(例如，智能因子)，以控制心理社会药物的提供，并允许确定最佳心理社会治疗。今后的研究还应确保更多地纳入种族/族裔和性/性别少数群体，并应在文化/语言上加以调整，以改善治疗参与度和研究结果。
Tobacco smoking is a major driver of premature mortality in people with serious mental illness (SMI; e.g., schizophrenia, bipolar disorder). This systematic literature review described randomized control trials of psychosocial smoking cessation interventions for people with SMI, rated their methodological rigor, evaluated the inclusion of racial/ethnic and sexual/gender minorities, and examined smoking cessation outcomes. Eligible studies included peer-reviewed articles published between 2009 and 2020 that examined psychosocial smoking cessation interventions in people with SMI. We used the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines to conduct our review and the Methodological Quality Rating Scale to evaluate methodological rigor. Eighteen studies were included. Ten were categorized as high methodological rigor given their study characteristics (e.g., longer follow-up) and eight as lower methodological rigor based on their characteristics (e.g., not intent-to-treat). Racial/ethnic and sexual/gender minorities were underrepresented in these studies. A range of psychosocial interventions were examined including motivational enhancements, smoking cessation education, cognitive behavioral strategies, and contingency management. Most studies also provided smoking cessation medications (e.g., NRT, bupropion), although provision was not always uniform across treatment conditions. Nine studies found the intervention condition achieved significantly higher smoking abstinence or reduction compared to the comparison group. The most promising psychosocial smoking cessation interventions seemed to be initiated in inpatient psychiatric units and employed either a transtheoretical approach (i.e., stage-tailored, decisional balance) or individually-tailored telephone behavioral smoking counseling using a motivational-interviewing framework. Clinical trial designs (e.g., SMART, factorial) that control for the provision of psychosocial medications and allow for the identification of optimal psychosocial treatments are needed. Future studies should also ensure greater inclusion of racial/ethnic and sexual/gender minorities and should be culturally/linguistically adapted to improve treatment engagement and study outcomes.
登录
查看更多内容
影响因子：
3.9
作者：
Das S;Prochaska JJ
通讯作者：
Prochaska JJ
影响因子：
4.8
作者：
Callaghan, Russell C.;Veldhuizen, Scott;Gatley, Jodi
通讯作者：
Gatley, Jodi
影响因子：
9.3
作者：
Begh R;Lindson-Hawley N;Aveyard P
通讯作者：
Aveyard P
影响因子：
6.7
作者：
Depp CA;Bowie CR;Mausbach BT;Wolyniec P;Thornquist MH;Luke JR;McGrath JA;Pulver AE;Patterson TL;Harvey PD
通讯作者：
Harvey PD
影响因子：
4.7
作者：
Brody, Arthur L.;Zorick, Todd;McCreary, Charles
通讯作者：
McCreary, Charles